Dimensional Fund Advisors LP Purchases 2,890 Shares of Synopsys, Inc. (NASDAQ:SNPS)

Dimensional Fund Advisors LP boosted its position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 1.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 289,387 shares of the semiconductor company’s stock after acquiring an additional 2,890 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Synopsys were worth $111,758,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Freedom Wealth Alliance LLC acquired a new position in shares of Synopsys in the fourth quarter valued at $26,000. Ancora Advisors LLC acquired a new position in shares of Synopsys in the fourth quarter valued at $30,000. HHM Wealth Advisors LLC acquired a new position in shares of Synopsys in the first quarter valued at $31,000. Compagnie Lombard Odier SCmA increased its holdings in shares of Synopsys by 470.0% in the fourth quarter. Compagnie Lombard Odier SCmA now owns 114 shares of the semiconductor company’s stock valued at $36,000 after purchasing an additional 94 shares during the last quarter. Finally, Washington Trust Advisors Inc. acquired a new position in shares of Synopsys in the first quarter valued at $36,000. 84.12% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have commented on SNPS. Rosenblatt Securities reiterated a “buy” rating and issued a $485.00 price objective on shares of Synopsys in a report on Wednesday, August 23rd. JPMorgan Chase & Co. upped their price objective on shares of Synopsys from $470.00 to $500.00 and gave the company an “overweight” rating in a report on Thursday, August 17th. Needham & Company LLC reiterated a “buy” rating and issued a $500.00 price objective on shares of Synopsys in a report on Tuesday, August 15th. Stifel Nicolaus upped their price target on shares of Synopsys from $445.00 to $470.00 and gave the company a “buy” rating in a research note on Thursday, August 17th. Finally, KeyCorp upped their price target on shares of Synopsys from $500.00 to $515.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Synopsys has an average rating of “Buy” and an average price target of $462.50.

Get Our Latest Report on SNPS

Insider Transactions at Synopsys

In other news, CAO Sudhindra Kankanwadi sold 5,100 shares of the stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $460.75, for a total value of $2,349,825.00. Following the completion of the transaction, the chief accounting officer now owns 16,793 shares of the company’s stock, valued at $7,737,374.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, insider John F. Runkel, Jr. sold 2,507 shares of the firm’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $454.35, for a total value of $1,139,055.45. Following the completion of the transaction, the insider now owns 24,697 shares in the company, valued at approximately $11,221,081.95. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CAO Sudhindra Kankanwadi sold 5,100 shares of the firm’s stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $460.75, for a total transaction of $2,349,825.00. Following the completion of the transaction, the chief accounting officer now owns 16,793 shares of the company’s stock, valued at approximately $7,737,374.75. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 97,703 shares of company stock valued at $43,025,310. 0.69% of the stock is currently owned by insiders.

Synopsys Trading Down 1.6 %

SNPS stock opened at $458.09 on Friday. The stock has a market capitalization of $69.68 billion, a P/E ratio of 68.68, a price-to-earnings-growth ratio of 3.61 and a beta of 1.11. Synopsys, Inc. has a 12 month low of $267.00 and a 12 month high of $471.15. The firm has a 50-day moving average price of $444.79 and a 200-day moving average price of $410.15.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its earnings results on Wednesday, August 16th. The semiconductor company reported $2.88 EPS for the quarter, topping analysts’ consensus estimates of $2.74 by $0.14. The firm had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. Synopsys had a net margin of 18.71% and a return on equity of 18.01%. The business’s revenue for the quarter was up 19.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.43 earnings per share. As a group, equities analysts predict that Synopsys, Inc. will post 7.87 EPS for the current fiscal year.

About Synopsys

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Recommended Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.